Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells

Hoda Elkafas, Qiwei Yang, Ayman Al-Hendy

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Uterine fibroids (UFs) are the most frequent gynecologic tumors, affecting 70 to 80% of women over their lifetime, Although these tumors are benign, they can cause significant morbidity and may require invasive treatments such as myomectomy and hysterectomy in premenopausal women at a cost of up to $34 billion per year. Many risk factors for these tumors have been identified, including environmental exposures to endocrine-disrupting chemicals such as genistein and diethylstilbestrol (and other environmental agents) resulting in hyper-responsiveness to hormone in the adult uterus and promotion of hormone-dependent UFs. Although the molecular mechanisms underlying the pathogenesis of UFs is largely unknown, a growing body of evidence implicates unfavorable early-life environmental exposure and multiple biological pathways express as potentially import contributors. In this article, we will review the role of genetic and epigenetics in the conversion of myometrial stem cells to tumor (fibroid) initiating cells, and their role in UF development.

Original languageEnglish (US)
Pages (from-to)481-486
Number of pages6
JournalSeminars in Reproductive Medicine
Volume35
Issue number6
DOIs
StatePublished - Nov 1 2017

Fingerprint

Neoplastic Stem Cells
Leiomyoma
Stem Cells
Environmental Exposure
Uterine Myomectomy
Hormones
Endocrine Disruptors
Neoplasms
Diethylstilbestrol
Genistein
Hysterectomy
Epigenomics
Uterus
Morbidity
Costs and Cost Analysis

Keywords

  • biology of uterine fibroids
  • endocrine-disrupting chemicals
  • epigenetic reprograming
  • myometrial stem cells
  • tumor-initiating cells

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Reproductive Medicine
  • Endocrinology
  • Obstetrics and Gynecology
  • Physiology (medical)

Cite this

Origin of Uterine Fibroids : Conversion of Myometrial Stem Cells to Tumor-Initiating Cells. / Elkafas, Hoda; Yang, Qiwei; Al-Hendy, Ayman.

In: Seminars in Reproductive Medicine, Vol. 35, No. 6, 01.11.2017, p. 481-486.

Research output: Contribution to journalArticle

Elkafas, Hoda ; Yang, Qiwei ; Al-Hendy, Ayman. / Origin of Uterine Fibroids : Conversion of Myometrial Stem Cells to Tumor-Initiating Cells. In: Seminars in Reproductive Medicine. 2017 ; Vol. 35, No. 6. pp. 481-486.
@article{617599828ee04d26abfd9bbe669ff85c,
title = "Origin of Uterine Fibroids: Conversion of Myometrial Stem Cells to Tumor-Initiating Cells",
abstract = "Uterine fibroids (UFs) are the most frequent gynecologic tumors, affecting 70 to 80{\%} of women over their lifetime, Although these tumors are benign, they can cause significant morbidity and may require invasive treatments such as myomectomy and hysterectomy in premenopausal women at a cost of up to $34 billion per year. Many risk factors for these tumors have been identified, including environmental exposures to endocrine-disrupting chemicals such as genistein and diethylstilbestrol (and other environmental agents) resulting in hyper-responsiveness to hormone in the adult uterus and promotion of hormone-dependent UFs. Although the molecular mechanisms underlying the pathogenesis of UFs is largely unknown, a growing body of evidence implicates unfavorable early-life environmental exposure and multiple biological pathways express as potentially import contributors. In this article, we will review the role of genetic and epigenetics in the conversion of myometrial stem cells to tumor (fibroid) initiating cells, and their role in UF development.",
keywords = "biology of uterine fibroids, endocrine-disrupting chemicals, epigenetic reprograming, myometrial stem cells, tumor-initiating cells",
author = "Hoda Elkafas and Qiwei Yang and Ayman Al-Hendy",
year = "2017",
month = "11",
day = "1",
doi = "10.1055/s-0037-1607205",
language = "English (US)",
volume = "35",
pages = "481--486",
journal = "Seminars in Reproductive Medicine",
issn = "1526-8004",
publisher = "Thieme Medical Publishers",
number = "6",

}

TY - JOUR

T1 - Origin of Uterine Fibroids

T2 - Conversion of Myometrial Stem Cells to Tumor-Initiating Cells

AU - Elkafas, Hoda

AU - Yang, Qiwei

AU - Al-Hendy, Ayman

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Uterine fibroids (UFs) are the most frequent gynecologic tumors, affecting 70 to 80% of women over their lifetime, Although these tumors are benign, they can cause significant morbidity and may require invasive treatments such as myomectomy and hysterectomy in premenopausal women at a cost of up to $34 billion per year. Many risk factors for these tumors have been identified, including environmental exposures to endocrine-disrupting chemicals such as genistein and diethylstilbestrol (and other environmental agents) resulting in hyper-responsiveness to hormone in the adult uterus and promotion of hormone-dependent UFs. Although the molecular mechanisms underlying the pathogenesis of UFs is largely unknown, a growing body of evidence implicates unfavorable early-life environmental exposure and multiple biological pathways express as potentially import contributors. In this article, we will review the role of genetic and epigenetics in the conversion of myometrial stem cells to tumor (fibroid) initiating cells, and their role in UF development.

AB - Uterine fibroids (UFs) are the most frequent gynecologic tumors, affecting 70 to 80% of women over their lifetime, Although these tumors are benign, they can cause significant morbidity and may require invasive treatments such as myomectomy and hysterectomy in premenopausal women at a cost of up to $34 billion per year. Many risk factors for these tumors have been identified, including environmental exposures to endocrine-disrupting chemicals such as genistein and diethylstilbestrol (and other environmental agents) resulting in hyper-responsiveness to hormone in the adult uterus and promotion of hormone-dependent UFs. Although the molecular mechanisms underlying the pathogenesis of UFs is largely unknown, a growing body of evidence implicates unfavorable early-life environmental exposure and multiple biological pathways express as potentially import contributors. In this article, we will review the role of genetic and epigenetics in the conversion of myometrial stem cells to tumor (fibroid) initiating cells, and their role in UF development.

KW - biology of uterine fibroids

KW - endocrine-disrupting chemicals

KW - epigenetic reprograming

KW - myometrial stem cells

KW - tumor-initiating cells

UR - http://www.scopus.com/inward/record.url?scp=85032806491&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032806491&partnerID=8YFLogxK

U2 - 10.1055/s-0037-1607205

DO - 10.1055/s-0037-1607205

M3 - Article

AN - SCOPUS:85032806491

VL - 35

SP - 481

EP - 486

JO - Seminars in Reproductive Medicine

JF - Seminars in Reproductive Medicine

SN - 1526-8004

IS - 6

ER -